[1]
Belfeki, N. et al. 2016. Successful treatment of refractory adult onset Still’s disease with rituximab. Reumatismo. 68, 3 (Dec. 2016), 159–162. DOI:https://doi.org/10.4081/reumatismo.2016.888.